Koichi Miyata

Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study

Koichi Miyata, Tetsuji Kaneko, Yoshihiko Morikawa et al. · The Lancet Child & Adolescent Health · 2018 · 94 citations

Rheumatology, Post Raise, Autoimmune Disease +7

Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease

Koichi Miyata, Masaru Miura, Tetsuji Kaneko et al. · Circulation Cardiovascular Quality and Outcomes · 2021 · 31 citations

Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis

Koichi Miyata, Emelia Bainto, Xiaoying Sun et al. · Archives of Disease in Childhood · 2023 · 25 citations · Full text

Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE

Kazuki Iio, Yoshihiko Morikawa, Koichi Miyata et al. · The Journal of Pediatrics · 2021 · 19 citations

Post Raise, Cardiovascular Disease, Atherosclerosis +7

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease

Kirsten Dummer, Koichi Miyata, Chisato Shimizu et al. · JAMA Network Open · 2023 · 17 citations · Full text

Thrombosis, Direct Oral Anticoagulants, Cardiovascular Disease +9